TearClear is a pharmaceutical company that specializes in providing a disruptive eye health technology.
TearClear has raised $11.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.
TearClear's investors include Visionary Venture Fund, Bluestem Capital, Flying L Partners.
TearClear is headquartered in Boston, United States.
TearClear is a pharmaceutical company that specializes in providing a disruptive eye health technology.
TearClear is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TearClear — Funding & Investors." VCBacked, July 11, 2023, https://www.vcbacked.co/company/tearclear. Accessed August 8, 2026.
VCBacked. (2023). TearClear — Funding & Investors. Retrieved August 8, 2026, from https://www.vcbacked.co/company/tearclear
{{cite web |title=TearClear — Funding & Investors |url=https://www.vcbacked.co/company/tearclear |website=VCBacked |access-date=August 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated